AbCellera Biologics Inc (NASDAQ:ABCL) has a beta value of 0.36 and has seen 1.8 million shares traded in the last trading session. The company, currently
In the last trading session, 1.82 million shares of the AbCellera Biologics Inc (NASDAQ:ABCL) were traded, and its beta was 0.35. Most recently the company’s
In the last trading session, 2.5 million shares of the AbCellera Biologics Inc (NASDAQ:ABCL) were traded, and its beta was 0.35. Most recently the company’s
AbCellera Biologics Inc (NASDAQ:ABCL)’s traded shares stood at 3.27 million during the last session, with the company’s beta value hitting 0.36. At the close of
In the last trading session, 4.0 million AbCellera Biologics Inc (NASDAQ:ABCL) shares changed hands as the company’s beta touched 0.43. With the company’s per share
In the latest trading session, 0.98 million AbCellera Biologics Inc (NASDAQ:ABCL) shares changed hands as the company’s beta touched 0.43. With the company’s most recent
In last trading session, AbCellera Biologics Inc (NASDAQ:ABCL) saw 2.35 million shares changing hands with its beta currently measuring 0.36. Company’s recent per share price
AbCellera Biologics Inc (NASDAQ:ABCL) has a beta value of 0.34 and has seen 3.84 million shares traded in the last trading session. The company, currently
AbCellera Biologics Inc (NASDAQ:ABCL) has a beta value of 0.35 and has seen 3.63 million shares traded in the last trading session. The company, currently
During the last session, AbCellera Biologics Inc (NASDAQ:ABCL)’s traded shares were 1.23 million, with the beta value of the company hitting 0.37. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
